Glomerular Disease Study & Trial Consortium
A Clinical, Scientific, & Educational Collaboration...
The Glomerular Disease Study & Trial Consortium (GlomCon) is a mission-driven nonprofit charitable 501(c)(3) organization registered in the U.S.A. Our mission is to provide unbiased global medical education based on the best available evidence and create a platform for research collaboration among clinicians, academics, and industry partners guided by patients’ and their caregivers’ needs.
GLOMCON BY NUMBERS
As of May 2023, GlomCon has conducted more than 250 life seminars spanning from case-specific discussions of diagnostic and therapeutic challenges, review of new scientific discoveries, and introduction of new concepts and paradigms by leading experts in the field of glomerular diseases and nephrology. The weekly attendance of these life seminars enjoys one of the highest attendance rates in this field (120 – 330 life participants from academia, private practice, industry, and government). Further, our global audience has watched the archived seminars on YouTube more than half a million times (now all moved to my.glomcon.org).
On the Horizon
An initiative to learn, teach, and disseminate the latest therapeutic advances in glomerular diseases.
Supported through educational grants from Travere Therapeutics and Vertex Pharmaceuticals, this program will provide scientific and clinical information about therapeutics under investigaton or recently approved.
GlomCon's Corporate Supporters
We gratefully acknowledge the support and partnership of corporations dedicated to improving the lives of patients with glomerular diseases.
The support from our corporate members and our strategic partners allows us to come up with bold ideas and helps us pursue our mission.
GlomCon Around The World
GlomCon is a global network that is dedicated to promoting international exchanges and collaborations. One of the key ways that GlomCon achieves this goal is through its country initiatives, which are designed to support local nephrology and patient communities and leverage local expertise around the world.
Each country's initiative is tailored to the unique needs and challenges of the region it serves.